Drug Candidate Absorbed via Lymphatic System Targets Cancer Cells in Mice - Genetic Engineering & Biotechnology News

Orally administered compound is first taken up by lymphatic system, and simultaneously targets both the PI3K and MAPK signaling pathways.

A team of University of Michigan researchers has developed a new anti-cancer drug that is absorbed through the guts lymphatic system rather than blood vessels, potentially outmaneuvering the molecula… [+6478 chars]

full article...